BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21874572)

  • 1. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects.
    Al-Wahsh I; Wu Y; Liebman M
    Urol Res; 2012 Jun; 40(3):191-6. PubMed ID: 21874572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects.
    Okombo J; Liebman M
    Urol Res; 2010 Jun; 38(3):169-78. PubMed ID: 20224931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.
    Mikami K; Akakura K; Takei K; Ueda T; Mizoguchi K; Noda M; Miyake M; Ito H
    Int J Urol; 2003 Jun; 10(6):293-6. PubMed ID: 12757596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of increased oxalate absorption in patients with calcium-containing renal stones.
    Hodgkinson A
    Clin Sci Mol Med; 1978 Mar; 54(3):291-4. PubMed ID: 630804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal and renal handling of oxalate loads in normal individuals and stone formers.
    Knight J; Holmes RP; Assimos DG
    Urol Res; 2007 Jun; 35(3):111-7. PubMed ID: 17431604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial roles of gastrointestinal and urinary microbiomes in kidney stone prevention via their oxalate-degrading ability and beyond.
    Noonin C; Thongboonkerd V
    Microbiol Res; 2024 May; 282():127663. PubMed ID: 38422861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model: A new strategy.
    Afkari R; Feizabadi MM; Ansari-Moghadam A; Safari T; Bokaeian M
    Int Braz J Urol; 2019; 45(6):1249-1259. PubMed ID: 31808414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
    Marangella M; Fruttero B; Bruno M; Linari F
    Clin Sci (Lond); 1982 Oct; 63(4):381-5. PubMed ID: 7105633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR; Reid SJ
    Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics and other key determinants of dietary oxalate absorption.
    Liebman M; Al-Wahsh IA
    Adv Nutr; 2011 May; 2(3):254-60. PubMed ID: 22332057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion.
    Thomas E; von Unruh GE; Hesse A
    Eur J Clin Nutr; 2008 Sep; 62(9):1090-7. PubMed ID: 17609696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.
    Chai W; Liebman M; Kynast-Gales S; Massey L
    Am J Kidney Dis; 2004 Dec; 44(6):1060-9. PubMed ID: 15558527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.